Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Naoual Dahmana"'
Autor:
Robert Gurny, Francine Behar-Cohen, Doris Gabriel, Yogeshvar N. Kalia, Laura Kowalczuk, Tatiana Favez, Naoual Dahmana, Thibault Mugnier
Publikováno v:
International Journal of Pharmaceutics
International Journal of Pharmaceutics, Elsevier, 2021, pp.120773. ⟨10.1016/j.ijpharm.2021.120773⟩
International Journal of Pharmaceutics, 2021, pp.120773. ⟨10.1016/j.ijpharm.2021.120773⟩
International journal of pharmaceutics, vol. 604, pp. 120773
International Journal of Pharmaceutics, Elsevier, 2021, pp.120773. ⟨10.1016/j.ijpharm.2021.120773⟩
International Journal of Pharmaceutics, 2021, pp.120773. ⟨10.1016/j.ijpharm.2021.120773⟩
International journal of pharmaceutics, vol. 604, pp. 120773
Impaired wound healing in patients receiving glucocorticoid therapy is a serious clinical concern: mineralocorticoid receptor (MR) antagonists can counter glucocorticoid-induced off-target activation of MR receptors. The aim of this study was to inve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c4ab3600839725eea7ce57d7f0b9cd4
https://hal.sorbonne-universite.fr/hal-03252204/document
https://hal.sorbonne-universite.fr/hal-03252204/document
Autor:
Naoual Dahmana, Yogeshvar N. Kalia, Laura Kowalczuk, Francine Behar-Cohen, Robert Gurny, Doris Gabriel
Publikováno v:
Molecular Pharmaceutics, Vol. 17, No 1 (2020) pp. 59-69
Sustained-release formulations for ocular delivery are of increasing interest given their potential to significantly improve treatment efficacy and patient adherence. The objectives of this study were (i) to develop a sustained-release formulation of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02e076219ac88db91770d186cb735533
https://archive-ouverte.unige.ch/unige:138463
https://archive-ouverte.unige.ch/unige:138463
Autor:
Doris Gabriel, Thierry Bertaim, Vassilios Kaltsatos, Yogeshvar N. Kalia, Thibault Mugnier, Robert Gurny, Naoual Dahmana, Francine Behar-Cohen
Publikováno v:
Molecular Pharmaceutics. 15:1192-1202
The objective was to investigate whether mineralocorticoid receptor antagonism using a novel topical micellar formulation of spironolactone could prevent glucocorticoid-induced delayed corneal wound healing in New Zealand white rabbits. Spironolacton
Publikováno v:
Biomedical Chromatography. 32:e4287
Glucocorticoids are a mainstay for the treatment of immune-mediated conditions and inflammatory diseases. However, their chronic use causes numerous side-effects including delays in corneal and cutaneous wound healing. This is attributed to off-targe